TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma

Keyphrases

• Hepatocellular Carcinoma 100%
• Hepatic Metastasis 100%
• Liver 20%
• Tumor 20%
• Cancer Patients 20%
• Therapeutic Efficacy 20%
• Antimetastatic Effect 20%
• Oral Administration 20%
• Cell Invasion 20%
• Cell Migration 20%
• Activator protein-1 (AP-1) 20%
• Trimethylsilyl 20%
• Hepatoblastoma 20%
• Liver Cancer 20%
• Urokinase-type Plasminogen Activator 20%
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) 20%
• Benzoic Acid 20%
• Metastasis Model 20%
• Solitary Tumor 20%
• Orthotopic Implantation 20%
• Tumor Nodule 20%
• Antiactivator 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Liver Cell Carcinoma 100%
• Liver Cancer 50%
• Combination Therapy 50%
• Receptor 50%
• Transcription Factor AP 1 50%
• Urokinase 50%
• Isosorbide 50%
• Amsilarotene 50%

Medicine and Dentistry

• Hepatocellular Carcinoma 100%
• Metastatic Carcinoma 100%
• Neoplasm 40%
• Liver Cancer 20%
• Cell Migration 20%
• Combination Therapy 20%
• Receptor 20%
• Oral Drug Administration 20%
• Downregulation 20%
• Cell Invasion 20%
• Transcription Factor AP 1 20%
• Urokinase 20%
• Isosorbide 20%
• Amsilarotene 20%